WHO Grade III Glioma Recruiting Phase 2 Trials for Olaparib (DB09074)

IndicationStatusPhase
DBCOND0089571 (WHO Grade III Glioma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03212274Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 MutationsTreatment